Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.15915 http://scihub22266oqcxt.onion/10.1111/ajt.15915 32282982!7262146!32282982     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Transplant 2020 ; 20 (7): 1809-1818 Nephropedia Template TP {{tp|p=32282982|t=2020. Early impact of COVID-19 on transplant center practices and policies in the United States |pdf=|usr=}}{{32282982}} gab.com Text Early impact of COVID-19 on transplant center practices and policies in the United States JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32282982 #FOAvip COVID-19 is a novel, rapidly changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the United States, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24, 2020 and March 31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1 to >10 years posttransplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the United States; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices. Twit Text FOAVip Early impact of COVID-19 on transplant center practices and policies in the United States ????Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32282982 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32282982 #FOAvip English Wikipedia <ref>{{Cite pmid|32282982}}</ref> Early impact of COVID-19 on transplant center practices and policies in the United States #MMPMID32282982 Boyarsky BJ; Po-Yu Chiang T; Werbel WA; Durand CM; Avery RK; Getsin SN; Jackson KR; Kernodle AB; Van Pilsum Rasmussen SE; Massie AB; Segev DL; Garonzik-Wang JM Am J Transplant 2020[Jul]; 20 (7): 1809-1818 PMID32282982show ga COVID-19 is a novel, rapidly changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the United States, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24, 2020 and March 31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1 to >10 years posttransplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the United States; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices. |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques/statistics & numerical data[MESH] |Coronavirus Infections/diagnosis/drug therapy/*prevention & control/*transmission[MESH] |Critical Illness[MESH] |Evidence-Based Medicine[MESH] |Health Policy[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Incidence[MESH] |Kidney Failure, Chronic/complications/surgery[MESH] |Kidney Transplantation/statistics & numerical data/trends[MESH] |Liver Transplantation/statistics & numerical data/trends[MESH] |Living Donors[MESH] |Organ Transplantation/legislation & jurisprudence/statistics & numerical data/*trends[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control/*transmission[MESH] |Resource Allocation[MESH] |SARS-CoV-2[MESH] |Surveys and Questionnaires[MESH] |Tissue Donors[MESH] |Transplant Recipients[MESH]Early impact of COVID-19 on transplant center practices and policies i(epmc).pdf DeepDyve Pubget Overpricing